Eledon Pharmaceuticals (FRA:2TK) Sale Of Property, Plant, Equipment : €0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Eledon Pharmaceuticals Sale Of Property, Plant, Equipment?

Eledon Pharmaceuticals's sale of property, plant, equipment for the three months ended in Dec. 2024 was €0.00 Mil. It means Eledon Pharmaceuticals gained €0.00 Mil from selling property, plant, and equipment. Eledon Pharmaceuticals's sale of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Sep. 2024 ), Eledon Pharmaceuticals gained the same money from selling property, plant, and equipment in Dec. 2024 (€0.00 Mil).

Eledon Pharmaceuticals Sale Of Property, Plant, Equipment Historical Data

The historical data trend for Eledon Pharmaceuticals's Sale Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eledon Pharmaceuticals Sale Of Property, Plant, Equipment Chart

Eledon Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Sale Of Property, Plant, Equipment

Get a 7-Day Free Trial

Eledon Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Sale Of Property, Plant, Equipment	Get a 7-Day Free Trial															-	-	-	-	-

Eledon Pharmaceuticals Sale Of Property, Plant, Equipment Calculation

The amount earned to sell PPE.

Sale Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Eledon Pharmaceuticals Sale Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Eledon Pharmaceuticals's Sale Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.

Eledon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eledon Pharmaceuticals Inc (FRA:2TK) » Definitions » Sale Of Property, Plant, Equipment

Comparable Companies

Traded in Other Exchanges

ELDN:USA 2TK:Germany

Address

19900 MacArthur Boulevard, Suite 550, Irvine, CA, USA, 92612

Website

https://www.eledon.com

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Eledon Pharmaceuticals Headlines

No Headlines